CAR-T Cell Therapy: How It Works and What to Expect

If you or a loved one has been diagnosed with certain types of leukemia, lymphoma, or myeloma, you may have heard your care team mention CAR-T cell therapy as a treatment option. It’s one of the most significant advances in blood cancer care in the past decade — and for many patients whose cancer hasn’t responded to chemotherapy, it has opened the door to long-term remission, according to the National Cancer Institute.

But CAR-T therapy is also complex, and it’s normal to have questions before moving forward. Below, we walk through what CAR-T cell therapy is, how it works step by step, who it’s for, and what recovery looks like. If you’d rather talk it through with a specialist directly, you can also request a consultation with our hematology-oncology team.

What Is CAR-T Cell Therapy?

CAR-T stands for chimeric antigen receptor T-cell therapy. It’s a type of immunotherapy that reprograms your own immune cells to recognize and destroy cancer cells.

Normally, T cells — a type of white blood cell — patrol the body looking for threats like viruses and infected cells. Cancer cells are skilled at hiding from this immune surveillance. CAR-T therapy solves that problem by genetically modifying a patient’s T cells in a lab, giving them a new “receptor” that can specifically recognize a marker on cancer cells. Once re-infused into the body, these engineered cells act like a living, self-replicating drug that seeks out and destroys the cancer. 

As of 2026 CAR-T therapy is now used for several blood cancers, including certain forms of:

• B-cell acute lymphoblastic leukemia (ALL)
• Large B-cell lymphoma and other non-Hodgkin lymphomas
• Follicular lymphoma
• Mantle cell lymphoma
• Multiple myeloma

Research is also underway to extend CAR-T approaches beyond blood cancers, and some centers are exploring earlier use in the treatment course rather than only after relapse — so the list of who’s eligible continues to evolve. 

H2 How CAR-T Cell Therapy Works: Step by Step

1. Evaluation and Eligibility

Before anything else, your hematology-oncology team reviews your diagnosis, prior treatments, and overall health to confirm CAR-T therapy is an appropriate option. CAR-T is generally considered for patients whose cancer has relapsed or hasn’t responded to standard treatments like chemotherapy. Meet our hematology-oncology team to learn more about who will be guiding you through this evaluation.

2. T-Cell Collection (Leukapheresis)

Once approved, you’ll undergo a procedure called leukapheresis. Blood is drawn from your body, passed through a machine that separates out your T cells, and the remaining blood components are returned to you. This typically takes a few hours and can usually be done on an outpatient basis.

3. Manufacturing Your CAR-T Cells

Your T cells are sent to a specialized lab, where they’re genetically engineered to express the chimeric antigen receptor — the “homing device” that will let them recognize your specific cancer cells. The cells are then multiplied into the millions needed for treatment. Manufacturing has traditionally taken three to six weeks, but newer automated production systems are shortening that window — an important shift for patients with fast-progressing leukemia or lymphoma who can’t afford long delays. The NCI has a helpful visual walkthrough of this process if you’d like to see it laid out step by step.

4. Bridging Therapy (If Needed)

Because manufacturing takes time, some patients receive additional treatment — such as chemotherapy — to help keep the cancer under control while their CAR-T cells are being prepared.

5. Lymphodepleting Chemotherapy

A few days before your CAR-T infusion, you’ll receive a short course of chemotherapy. This step reduces the number of existing immune cells in your body, which helps your new CAR-T cells expand and establish themselves more effectively once infused.

6. Infusion

The engineered CAR-T cells are infused back into your bloodstream through an IV, much like a blood transfusion. This is typically a one-time treatment.

7. Monitoring and Recovery

After infusion, you’ll be closely monitored — often with a hospital stay of one to two weeks — because the immune response triggered by CAR-T cells can cause side effects that need prompt management. Some treatment centers now offer carefully structured outpatient CAR-T programs for eligible patients, with frequent check-ins in place of an extended hospital stay, though this depends on your specific case and treatment center. Recovery and monitoring generally continue for two to three months as your care team tracks how your body is responding.

What Are the Side Effects of CAR-T Cell Therapy?

Because CAR-T therapy works by activating a powerful immune response, it can come with side effects that are different from traditional chemotherapy. The two most closely monitored are:

• Cytokine release syndrome (CRS): A reaction caused by the rapid activation of immune cells, which can cause fever, low blood pressure, and flu-like symptoms. Most cases are manageable, especially with early recognition.
• Neurological effects (ICANS): Some patients experience temporary confusion, difficulty with speech, or other neurological symptoms, which typically resolve with treatment and monitoring.

This is why CAR-T therapy is administered at specialized centers with staff trained to recognize and manage these reactions quickly. Your care team will walk you through exactly what to watch for and when to reach out.

Is CAR-T Cell Therapy Right for You?

CAR-T therapy isn’t the right fit for every patient or every cancer type, and eligibility depends on factors like your specific diagnosis, prior treatments, and overall health. The best way to know if it’s an option for you is to talk with a hematology-oncology specialist who can review your full history — you can start by exploring our leukemia and lymphoma treatment page or reaching out directly.

If you’ve been told your cancer is relapsed or refractory, or if you simply want to understand all of your treatment options, our team is here to help you make sense of the path forward — including whether CAR-T therapy, a bone marrow transplant, or another approach makes the most sense for your situation.

Why Choose India for CAR-T Cell Therapy

For international patients weighing where to pursue CAR-T therapy, India has become a significant destination for advanced cancer treatment. According to موطن الرعاية الصحية, a medical tourism facilitator that connects international patients with hospitals across India, the country draws patients through a combination of internationally accredited hospitals, experienced specialists, modern treatment technology, and substantially lower costs than many Western countries.

A few factors patients typically weigh when considering India for CAR-T or other advanced hematology-oncology care:

• Cost. Given that CAR-T therapy can carry a total cost of care exceeding $1 million in some countries, the price difference for comparable treatment in India can be substantial — though exact figures depend on the hospital, the specific CAR-T product, and the patient’s individual treatment plan.
• Access to major hospital networks. India is home to large hospital groups as Home of Healthcare co ordinates and partners with the best hospitals in India dedicated cancer and hematology programs, including Apollo Hospitals, Fortis Healthcare, Medanta, Max Super Speciality Hospital, Artemis Hospital, and Manipal Hospitals — several of which have oncology and stem cell/cell therapy programs.
• Reduced wait times. International patients often cite shorter scheduling delays compared to health systems with longer queues for specialized treatments.
• Coordinated support for international patients. Facilitators like Home of Healthcare help arrange hospital selection, treatment cost estimates, travel, and accommodation, which can simplify a process that’s already logistically demanding for patients traveling from abroad.

If you’re an international patient exploring CAR-T therapy in India, it’s worth requesting a personalized cost estimate and confirming which specific CAR-T product a given hospital offers, since availability, eligibility criteria, and approved indications can vary by center. Our own hematology-oncology team is also happy to help you think through your options — including whether treatment closer to home or abroad makes more sense for your situation.

للتواصل مع دار الرعاية الصحية to connect with hospitals and specialists, get a personalized cost estimate, and get support with travel and logistics for your treatment journey.

Frequently Asked Questions